{"id":1619,"date":"2007-09-25T15:57:45","date_gmt":"2007-09-25T15:57:45","guid":{"rendered":"http:\/\/localhost:8888\/wordpress\/gadolinium_contrast_agent_-_a_dangerous_drug_in_mris\/"},"modified":"2024-12-17T16:11:58","modified_gmt":"2024-12-17T21:11:58","slug":"gadolinium-contrast-agent-a-dangerous-drug-in-mris","status":"publish","type":"post","link":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/","title":{"rendered":"Gadolinium Contrast Agent &#8211; A Dangerous Drug Under Investigation"},"content":{"rendered":"<p>Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents for years.  One of those agents does not appear to be as safe as once thought.  Gadolinium, or gadodiamide, is a contrast agent which allows an MRI to define normal tissue from abnormal tissue in the brain and body. The FDA declared Gadolinium safe for use in contrast MRI\u2019s in 1988.<\/p>\n<p>In June 2006, the FDA first notified health care professionals and the general public about the risks of a potentially fatal disease known as nephrogenic systemic fibrosis (NSF) associated with the use of gadolinium. Patients with NSF develop thickening of the skin and connective tissues that inhibits their ability to move and may result in broken bones. Other organs are at risk of thickening as well. The cause of NSF is not known and there is no consistently effective treatment of this condition.<\/p>\n<p>More recently, on May 23, 2007, the U.S. Food and Drug Administration (FDA) asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI).<\/p>\n<div class=\"read_more_link\"><a href=\"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/\"  title=\"Continue Reading Gadolinium Contrast Agent &#8211; A Dangerous Drug Under Investigation\" class=\"more-link\">Continue reading<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents for years. One of those agents does not appear to be as safe as once thought. Gadolinium, or gadodiamide, is a contrast agent which allows an MRI to define normal tissue from [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[44],"class_list":["post-1619","post","type-post","status-publish","format-standard","hentry","category-personal-injury-wrongful-death","tag-personal-injury"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gadolinium Contrast Agent - A Dangerous Drug Under Investigation &#8212; Trial Attorney Blog &#8212; September 25, 2007<\/title>\n<meta name=\"description\" content=\"Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents &#8212; September 25, 2007\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Gadolinium Contrast Agent - A Dangerous Drug Under Investigation &#8212; Trial Attorney Blog &#8212; September 25, 2007\" \/>\n<meta name=\"twitter:description\" content=\"Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents &#8212; September 25, 2007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Finch McCranie, LLP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gadolinium Contrast Agent - A Dangerous Drug Under Investigation &#8212; Trial Attorney Blog &#8212; September 25, 2007","description":"Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents &#8212; September 25, 2007","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/","twitter_card":"summary_large_image","twitter_title":"Gadolinium Contrast Agent - A Dangerous Drug Under Investigation &#8212; Trial Attorney Blog &#8212; September 25, 2007","twitter_description":"Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents &#8212; September 25, 2007","twitter_misc":{"Written by":"Finch McCranie, LLP","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/#article","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/"},"author":{"name":"Finch McCranie, LLP","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"headline":"Gadolinium Contrast Agent &#8211; A Dangerous Drug Under Investigation","datePublished":"2007-09-25T15:57:45+00:00","dateModified":"2024-12-17T21:11:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/"},"wordCount":298,"keywords":["Personal Injury"],"articleSection":["Personal Injury &amp; Wrongful Death"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/","url":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/","name":"Gadolinium Contrast Agent - A Dangerous Drug Under Investigation &#8212; Trial Attorney Blog &#8212; September 25, 2007","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#website"},"datePublished":"2007-09-25T15:57:45+00:00","dateModified":"2024-12-17T21:11:58+00:00","author":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"description":"Many of us who have handled serious personal injury cases, including those involving brain injury have seen MRI\u2019s performed using various contrast agents &#8212; September 25, 2007","breadcrumb":{"@id":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.finchmccranie.com\/blog\/gadolinium-contrast-agent-a-dangerous-drug-in-mris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.finchmccranie.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Gadolinium Contrast Agent &#8211; A Dangerous Drug Under Investigation"}]},{"@type":"WebSite","@id":"https:\/\/www.finchmccranie.com\/blog\/#website","url":"https:\/\/www.finchmccranie.com\/blog\/","name":"Trial Attorney Blog","description":"Published by Georgia Trial Lawyers \u2014 Finch McCranie, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.finchmccranie.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4","name":"Finch McCranie, LLP","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","caption":"Finch McCranie, LLP"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/comments?post=1619"}],"version-history":[{"count":1,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1619\/revisions"}],"predecessor-version":[{"id":33551,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1619\/revisions\/33551"}],"wp:attachment":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/media?parent=1619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/categories?post=1619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/tags?post=1619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}